With previously untreated Stage 3 or 4 Hodgkin lymphoma, first steps matter
Use the information below to familiarize yourself with important treatment considerations that can help you feel confident about the discussion, and your treatment choice.
Treatment considerations for classical Hodgkin lymphoma
Learn more about what to consider when deciding on treatment, and see why ADCETRIS may be the right option for you.
Brandon was treated with ADCETRIS plus AVD
Here’s some things to consider:
- How treatments work to kill cancer cells.
- How well they may stop or slow the progress of your cancer.
- How well they may improve overall survival.
- How well results may be maintained long-term.
- How side effects compare among treatments, and how they may be managed.
- Dosing and how treatments are given.
- The type of patient support available during treatment.
Our Treatment Decision Guide can help
This downloadable guide helps answer these and other questions many new Hodgkin lymphoma patients have.
Use the guide to review the effectiveness of ADCETRIS plus AVD, a newer option for previously untreated advanced stage Hodgkin lymphoma as compared to ABVD, a commonly prescribed chemotherapy treatment.
Your first treatment choice matters
DID YOU KNOW:
Up to 30% of people with previously untreated Stage 3 or 4 Hodgkin lymphoma who received traditional chemotherapy relapse or did not respond to treatment?
Your treatment, your choice
Your voice matters when it comes to making a first-time treatment decision for Stage 3 or 4 classical Hodgkin lymphoma
Your doctor may not mention ADCETRIS plus AVD as an option. While they are the expert regarding your diagnosis, you and your care team are equal partners in the treatment decision. Your perspective and concerns play an essential role in selecting a treatment that works for you.
- Don’t hesitate to speak up and ask questions.
- Familiarize yourself with all available treatments.
- It’s OK to propose an option your doctor may not mention.
- Seek a second opinion if that will help you feel confident about your choice.
Relapsed classical Hodgkin lymphoma
For some people, cancer may relapse after initial treatment (stem cell transplant).
For others, certain treatments may not work to control tumor growth or treat cancer. However, they may still benefit from treatment with ADCETRIS if they failed at least 2 chemotherapy treatments and stem cell transplant is not an option.
See how ADCETRIS worked in people with relapsed classical Hodgkin lymphoma.
Consolidation after stem cell transplant
Sometimes people receive a stem cell transplant if their disease comes back after initial treatment.
ADCETRIS may be given to reduce the risk of relapse or worsening disease. This is called consolidation treatment.
See how ADCETRIS worked in people given as consolidation treatment.
Glossary
ABVD: A combination of 4 chemotherapies—Adriamycin, bleomycin, vinblastine, and dacarbazine.
AVD: A combination of 3 chemotherapies—Adriamycin, vinblastine, and dacarbazine.
Consolidation treatment: Treatment that aims to kill any cancer cells that may be left in the body after initial treatment.
Relapse: When cancer has returned after a period of remission.
Remission: When signs and symptoms of cancer are reduced or undetectable.
Mary Ann’s treatment journey
Mary Ann was diagnosed with Stage 4 Hodgkin lymphoma while going through major changes in her life. She researched her available treatments and built a strong partnership with her oncologist and care team to reach a treatment decision.
Researching treatments and discussing options
Considering the benefits and risks of each treatment
Making the decision to treat with ADCETRIS
ADCETRIS will not work for everyone.
